Meningioma as second malignant neoplasm after oncological treatment during childhood

Strahlenther Onkol. 2012 May;188(5):438-41. doi: 10.1007/s00066-012-0082-7. Epub 2012 Mar 14.

Abstract

A total of 38 patients (18 female/20 male) with childhood meningioma were recruited from the German registry HIT-Endo (1989-2009). In 5 cases meningioma occurred as second malignant neoplasm (SMN). Histologies were confirmed by reference assessment in all cases (SMN: 2 WHO I, 1 WHO II, 2 WHO III). The SMNs were diagnosed at a median age of 12.4 years with a median latency of 10.2 years after primary malignancy (PMN; 4 brain tumors, 1 lymphoblastic leukemia; median age at diagnosis 2.7 years). Meningioma occurred as SMN in the irradiated field of PMN (range 12-54 Gy). The outcome after treatment of SMN meningioma (surgery/irradiation) was favorable in terms of psychosocial status and functional capacity in 4 of 5 patients (1 death). We conclude that survivors of childhood cancer who were exposed to radiation therapy at young age harbor the risk of developing meningioma as a SMN at a particularly short latency period in case of high dose exposure.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / pathology*
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / surgery
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Male
  • Meningeal Neoplasms / diagnosis
  • Meningeal Neoplasms / drug therapy
  • Meningeal Neoplasms / radiotherapy
  • Meningeal Neoplasms / secondary*
  • Meningeal Neoplasms / surgery
  • Meningioma / diagnosis
  • Meningioma / drug therapy
  • Meningioma / radiotherapy
  • Meningioma / secondary*
  • Meningioma / surgery
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
  • Treatment Outcome

Substances

  • Antineoplastic Agents